NCT03033719

Brief Summary

The purpose of this study is to compare the postoperative global morbidity between patients who have been operated on for a colon cancer by laparotomy and those operated on by laparoscopy

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
276

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 10, 2017

Completed
17 days until next milestone

First Posted

Study publicly available on registry

January 27, 2017

Completed
5 months until next milestone

Study Start

First participant enrolled

July 4, 2017

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2020

Completed
Last Updated

January 12, 2018

Status Verified

January 1, 2018

Enrollment Period

2.7 years

First QC Date

January 10, 2017

Last Update Submit

January 11, 2018

Conditions

Keywords

Colorectal SurgeryGeriatricsDigestive OncologyColon cancerElderly patientsLaparoscopyLaparotomyMorbidity

Outcome Measures

Primary Outcomes (1)

  • Global postoperative morbidity in both arms

    Postoperative morbidity is defined as any surgical or medical complications occurring up to 30 days after surgery. It will be collected using a standardized collection form during hospitalization and eventual subsequent consultations in case of patient discharge before then

    At 30 days after the surgery

Secondary Outcomes (11)

  • Postoperative mortality

    Evaluated at 30 days and at 90 days after the surgery

  • Rate of readmission

    Within the 30 days after discharge of the patient

  • Number of examined lymph nodes

    At surgery

  • Type of resection (R0 or R1)

    At surgery

  • Pathological evaluation of mesocolic resection quality

    At surgery

  • +6 more secondary outcomes

Other Outcomes (4)

  • To establish a specific molecular classification of colon cancer in the elderly from expression chips

    within the 15 years after the tumor sampling

  • To establish associations between molecular subtypes, the clinical and histological factors and relevant genetic alterations

    within the 15 years after the tumor sampling

  • To establish a possible link between these molecular subtypes and overall survival of patients

    within the 15 years after the tumor sampling

  • +1 more other outcomes

Study Arms (2)

Laparotomy

ACTIVE COMPARATOR

Open surgery

Procedure: Laparotomy

Laparoscopy

EXPERIMENTAL

Minimally invasive surgery

Procedure: Laparoscopy

Interventions

LaparotomyPROCEDURE

Open surgery

Also known as: Open surgery
Laparotomy
LaparoscopyPROCEDURE

Minimally invasive surgery

Also known as: Minimally invasive surgery
Laparoscopy

Eligibility Criteria

Age75 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Age ≥ 75 years
  • Histologically proven colonic adenocarcinoma (\> 15 cm from the anal margin) or precancerous colonic lesion non endoscopically resectable
  • Uncomplicated colonic tumor (no preoperative suspicion of invasion of adjacent structures as assessed by CT-scan (cT4), no tumoral perforation, or tumoral obstruction, or abscess, or hemorrhage)
  • No previous colonic cancer within the 5 last years
  • No peritoneal carcinosis on CT-scan
  • Patient able to fill in an auto-questionnaire alone or with some help
  • MMS (Mini Mental Score) ≥ 15
  • Given oral consent (formal informed consent is not required by French law for accepted procedures)

You may not qualify if:

  • Rectal cancer (≤ 15 cm from the anal margin)
  • Locally advanced (cT4) or complicated tumor requiring extended resection or emergency surgery
  • Synchronous colonic cancer
  • \- Scheduled need for synchronous intra-abdominal surgery, including surgery for liver metastases
  • Absolute contraindications to general anesthesia or prolonged pneumoperitoneum
  • Patient not able to tolerate colon surgery according to the global comprehensive geriatric assessment
  • Estimated life expectancy less than 6 months
  • Patient under guardianship
  • Other known active cancer (except nonmelanomatous skin cancer)
  • Patient not affiliated to the social security system
  • Previous colonic resection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Groupe Hospitalier Pitié Salpêtrière

Paris, 75013, France

RECRUITING

Related Publications (1)

  • Manceau G, Brouquet A, Chaibi P, Passot G, Bouche O, Mathonnet M, Regimbeau JM, Lo Dico R, Lefevre JH, Peschaud F, Facy O, Volpin E, Chouillard E, Beyert-Berjot L, Verny M, Karoui M, Benoist S. Multicenter phase III randomized trial comparing laparoscopy and laparotomy for colon cancer surgery in patients older than 75 years: the CELL study, a Federation de Recherche en Chirurgie (FRENCH) trial. BMC Cancer. 2019 Dec 4;19(1):1185. doi: 10.1186/s12885-019-6376-8.

MeSH Terms

Conditions

Colonic Neoplasms

Interventions

LaparotomyConversion to Open SurgeryLaparoscopyMinimally Invasive Surgical Procedures

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal Diseases

Intervention Hierarchy (Ancestors)

Surgical Procedures, OperativeEndoscopyDiagnostic Techniques, SurgicalDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Gilles MANCEAU, M.D., PhD.,

    Assistance Publique - Hôpitaux de Paris

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Gilles MANCEAU, M.D., PhD.,

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 10, 2017

First Posted

January 27, 2017

Study Start

July 4, 2017

Primary Completion

April 1, 2020

Study Completion

June 1, 2020

Last Updated

January 12, 2018

Record last verified: 2018-01

Data Sharing

IPD Sharing
Will not share

Locations